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Abst rac t
Introduction: According to the reports of the United States National Bureau of Statistics regarding the prevalence 
of obesity among adults and children and also asthma outbreak, the relationship between asthma and obesity in 
developed countries is taken into consideration. 
Aim: Relationship between body mass index and increased airway reactivity based on methacholine challenge test 
results.
Material and methods: It was a retrospective cross-sectional study done on 256 patients who were referred to the 
lung clinic of the Imam Khomeini Hospital of Ahvaz with symptoms of hypersensitivity of the airways. The patients, 
who had normal spirometry, were examined by the methacholine challenge test and then they were divided in two 
groups with positive and negative test results. 
Results: The patients of this study were 12–84 years old and their average age was 36.3 ±12.1 years. Their mean body 
mass index (BMI) was 28 ±4.7 kg/m2 in the group with positive methacholine and 26.7 ±4.9 kg/m2 in the group with 
negative methacholine (p = 0.04). It was shown that there has been a statistically significant relationship between 
BMI and positive methacholine challenge test results (apart from confounding effects of other variables). It seems 
that the positivity rate of methacholine test rises by 1.06 with an increase in BMI by each unit (p < 0.05).
Conclusions: According to the results of this study, it can be said that in high BMI there is a statistically significant 
association between gender (female) and a positive methacholine challenge test result; but there is no statistically 
significant association between the methacholine dose and BMI.
Key words: methacholine, body mass index, hypersensitivity of the airways.
Introduction
Asthma is the most common chronic disease around 
the world, so now about 300 million people are infected 
with this disease. For 30 years the prevalence of asthma 
has increased in rich countries, as currently it affects 
about 10–12% of adults and 15% of children. In develop-
ing countries, where the prevalence of asthma has been 
much lower, now it seems raised due to urbanization in-
crease. At the same time, the prevalence of atopy and 
other allergic diseases has increased. A physiological 
disorder characterized by asthma is airway hyperrespon-
siveness (AHR) [1]. The bronchial constriction occurs in 
response to different inhaled stimuli. So, one of the goals 
of asthma treatment is to reduce AHR [1, 2]. Increased 
bronchial hypersensitivity and bronchial constrictions oc-
cur with direct administration of bronchodilators such as 
histamine and methacholine, which cause constriction of 
bronchial smooth muscles [3]. According to stimulating 
factors for asthma, there is a relationship between some 
agents and asthma. Some factors cause asthma such as 
atopy, air pollution, diet lacking antioxidant, polyvalent 
unsaturated fats omega 3, allergens in the environment 
and cigarettes [4].
Recently, the relationship between asthma and obesi-
ty has been considered in developing countries and some 
related studies have been conducted. Vital capacity has 
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a significant association with body mass index (BMI). In 
obese persons, their chest expansion is reduced and also 
they have limitations in increasing the lung volumes [5]. 
There are controversies about the relationship between 
AHR and obesity. The association between them has not 
been proved yet [6]. 
Aim
The aim of this study is to evaluate the association 
between BMI and increased AHR based on methacholine 
challenge test results.
Material and methods
Methods
This research was a cross-sectional descriptive and ana-
lytic study in which the relationship between BMI and in-
creased airway reactivity based on methacholine challenge 
test results in the Khuzestan province was assessed.
Place of the study
This research was carried out in the Khuzestan prov-
ince, which is one of the southwestern provinces in Iran. 
This research comprised the patients who were referred 
to the lung clinic of the Imam Khomeini Hospital, affili-
ated to the Ahvaz Jundishapur University of Medical Sci-
ence.
Materials
Study data were collected for the adult patients who 
were referred to the lung clinic of the Imam Khomeini 
Hospital with symptoms of cough, dyspnea or wheezing 
and lacking previous diagnosis of asthma (forced expira-
tory volume in 1 s (FEV
1
) < 70%, response to bronchodila-
tor). They were selected and had the spirometry test per-
formed based on criteria of American Thoracic Society/
exercise channel test (ATS/ECT).
Procedure
After obtaining approval from the Ethics Committee 
of the Medical University of Ahwaz, from Jun 1, 2015 to 
Apr 20, 2016 all people who were referred to the lung 
clinic were chosen as the target population. The aim of 
this study was to assess the relationship between obe-
sity and airway hyperresponsiveness to the methacholine 
challenge test. After participants gave informed consent 
and completed the testimonial, they entered the study. 
Then they were tested by the methacholine challenge 
test and the collected data were analyzed using statisti-
cal software SPSSv22.
Sample size and sampling method
The sampling method used in this study was based 
on the census and all 256 patients referred to the lung 
clinic in the Imam Khomeini Hospital were studied from 
Jun 1, 2015 to Apr 20, 2016.
Compliance with Ethical Standards
This study was funded by the Ahwaz Jundishapur 
University of Medical Sciences.
Ethical approval
All procedures performed in studies involving human 
participants were in accordance with the ethical commit-
tee of the Ahvaz Jundishapur University of Medical Sci-
ences with reference number: IR. AJUMS. REC. 1394. 80. 
Informed consent
Informed consent was obtained from all individual 
participants included in the study.
Inclusion and exclusion criteria
We have excluded those patients with:
1. Spirometry test result suggesting the diagnosis of 
asthma. 
2. Heart attack or stroke during at least 3 months.
3. Uncontrolled blood pressure (systolic blood pressure 
(SBP) > 200 mm Hg or diastolic blood pressure (DBP) 
> 100 mm Hg).
4. Known case of aortic aneurysm.
Inclusion criteria of patients in this study:
1. People who wake up at night because of shortness 
of breath and due to heart problems investigated but 
they have no heart problems.
2. Patients who have clinical symptoms of asthma (short-
ness of breath, wheezing and coughing) but had nor-
mal spirometry results.
3. Patients who had non-specific symptoms (chronic 
cough with or without shortness of breath).
4. Patients who were suspected of having occupational 
asthma (symptoms in the workplace).
5. Those who after contact with irritants (perfumes, de-
tergents, air pollution, etc.) may have increased sensi-
tivity of the airways.
6. Those who intend to get hired in sensitive jobs and are 
suspected to have had asthma (pilots, astronauts, or 
join the army, etc.).
The rest of patients took the methacholine challenge 
test based on the guideline of ATS/ECT taking into ac-
count contraindications.
Methacholine challenge test procedure
The methacholine challenge test was done via 2-min-
ute tidal breath. 
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In our study, methacholine challenge test doses 
were from 0.125 to 16 mg/ml so that at each stage, dose 
concentration doubled in comparison with the previous 
stage. For statistical analysis to evaluate the association 
of the methacholine dose and BMI, data were classified 
into three groups: ≤ 1 mg/ml, 1–4 mg/ml, and ≥ 4 mg/ml. 
At any stage at which FEV
1 
> 20% was reduced, the test 
was considered positive and the intensity of this reactiv-
ity was identified according to the symptoms and reduc-
tion in FEV
1
 > 20% in the specified dose. In this research, 
the patients were asked a question about the drugs they 
have taken for the last 48 h. Taking drugs like Albuterol, 
Isoproterenol, Metaproterenol 8 h before the test, inter-
mediate-acting bronchodilators (Atrovent) 24 h before 
the test, long-acting bronchodilators (Formoterol, Tiotro-
pium bromide) 48 h before the test, Theophylline, Beta_2 
Agonists, Cromolyn sodium, Nedocromil, Hydroxyzine, 
Cetirizine, Leukotriene modifiers 12–48 h before the test 
should be avoided by the patients.
Methacholine is a crystalline powder that is dissolved 
in normal saline solution 0.9% without phenol. Thirty 
minutes before the test, the methacholine solution was 
taken from the refrigerator and 2 cc of the initial con-
centration was poured in the nebulizer; the patient was 
asked to sit in his own place in front of the device and 
using the nebulizer, to inhale the solution for 5 min and 
then we measured FEV
1
. After each inhalation, the place 
of the solution was thoroughly cleaned to prevent the 
drug accumulation effect. If FEV
1
 fell less than 20%, 2 cc 
of the next dose was poured into the nebulizer cham-
ber after emptying and drying the nebulizer, and if FEV
1
 
fell more than 20%, the next dose was not given to the 
patient and his symptoms were recorded and the alb-
uterol inhaler was given to him, then we waited 10 min 
and performed spirometry. During the test, the patient’s 
nose was closed with a nose clip. According to the ATS/
ECT guideline, the intensity of airway reactivity can be 
described as follows: 
a) If the methacholine dose to response is 16 mg/ml, 
it means lack of AHR. 
b) If the methacholine dose to response is 4.0–16 mg/
ml, it means borderline response to airway hypersensi-
tivity.
c) If the methacholine dose to response is 1.0–4.0 mg/ 
ml, it means mild response to AHR.
d) If the methacholine dose to response is 1 mg/ml, it 
means moderate to severe response to AHR [9].
Statistical analysis 
For data analysis in this study, descriptive statistic deter-
mination like frequency, mean, SD and analytical statistics 
such as independent two-sample t-test, χ2 and binary logis-
tic regression were used. In this research, the data were an-
alyzed with SPSS software (version 20) and p-value < 0.05 
was considered as a statistically significant level.
Results
The average age of the participants in this study was 
36.3 ±12.1 with the age range of 12–84 years. 46.5% (119 
patients) were males and 53.5% (137 patients) were fe-
males. The average BMI of the patients was about 27.3 
±4.8 kg/m2. In this research, 256 participants were divid-
ed into two groups of 128 patients based on positive and 
Table 1. Demographic and clinical characteristics of the participants in the study in terms of both positive and negative 
methacholine
Variables Negative methacholine (128) Positive methacholine (128) P-value
Age 36.7 ±12.1 35.8 ±12.1 0.86
Gender: 0.26
Male 64 (50%) 55 (43%)
Female 64 (50%) 73 (57%)
BMI [kg/m2]: 0.10
≤ 25 51 (39.8%) 35 (27.3%)
25.01–29.99 44 (34.4%) 52 (40.6%)
≥ 30 33 (25.8%) 41 (32%)
Methacholine inhaled dosage: > 0.001
≤ 1 0 (0%) 85 (66.4%)
1–4 2 (16%) 17 (13.3%)
≤ 4 126 (98.4%) 26 (20.3%)
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negative methacholine challenge test results. The aver-
age age of the participants in the positive methacholine 
group was 35.8 years and in the negative methacholine 
group – 36.7 years. In positive and negative methacholine 
groups, 55 (43%) patients and 64 (50%) patients were 
males, respectively. Other characteristics of the partici-
pants are shown in Table 1.
The average BMI of patients in the positive group 
was 28 ±4.7 kg/m2  and in the negative group it was 26.7 
±4.9 kg/m2, this difference in mean values is significant 
(p = 0.04). Also in checking data, distribution of partici-
pants into two groups – positive and negative metha-
choline ones based on their BMI, distinguishing three 
groups of physical parameters (i.e. BMI less than 25 kg/
m2, between 25.01 and 29.99 kg/m2, more than 30 kg/
m2) were investigated. The results showed that in the 
positive and negative methacholine groups, 33 and 41 
patients had BMI ≥ 30 and 44 kg/m2 and 52 patients had 
BMI 25.01–29.99 kg/m2, respectively, and that this differ-
ence was not statistically significant (p > 0.05). 
According to the assessment of frequency distribu-
tion of the relationship between BMI and the inhaled 
methacholine dose to the positive methacholine chal-
lenge test, for describing these data, it must be said that:
A. In the positive group with BMI ≥ 30 kg/m2:
• 68.3% (28 patients) with a minimum dose of metha-
choline (≤ 1 mg/ml), had hypersensitivity reactions of 
the airways (moderate to severe reactivity),
• 12.2% (5 patients) with 1–4 mg/ml dose of methacho-
line, had hypersensitivity reactions of the airways (mild 
reactivity),
• 19.5% of the group with ≥ 4 mg/ml dose of methacho-
line had hypersensitivity reactions of the airways (in-
termediate sensitivity);
B. In the positive group with BMI between 25.01 and 
29.99 kg/m2: 
• 71.2% (37 patients) were diagnosed with moderate to 
severe sensitivity,
• 15.4% (8 patients) were diagnosed with mild sensitiv-
ity,
• 13.5% (7 patients) were diagnosed with intermediate 
sensitivity;
C. In the positive group with BMI ≤ 25 kg/m2:
• 57.1% (20 patients) were diagnosed with moderate to 
severe sensitivity,
• 11.4% (4 patients) were diagnosed with mild sensitivity,
• 31.4% (11 patients) were diagnosed with intermediate 
sensitivity [7].
In data analysis, p-value was equal to 0.37, which 
means that in the positive methacholine test, there was 
no significant association between the dose of metha-
choline and BMI.
Also, in the survey of the relationship between the 
dose of methacholine and BMI, in the negative metha-
choline test, the results have shown no significant rela-
tionship (p = 0.054).
Finally, in the results of the logistic regression model 
to examine the variables like age, gender and BMI on 
the positivity rate of the methacholine challenge test, it 
was shown that there was a significant relationship be-
tween BMI variable and the positive methacholine chal-
lenge test in the crude analysis, which was meaningful 
disregarding the effect of other confounding variables. 
In other words, it seems that with any unit increase in 
BMI, the positivity rate of the methacholine challenge 
test rises by 1.06 (Table 2, Figure 1). 
It is remarkable that in this study, there is no statis-
tically relationship between age and sex (male-female) 
and the positivity rate of the methacholine challenge test 
(p > 0.05) (Table 3).
Discussion
In 2008, a study on 23 obese (BMI ≥ 30 kg/m2) and 
26 non-obese persons, among the non-asthmatic people 
Figure 1. Individual distribution of sub-groups based on 
body mass index (BMI)
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BMI_C      ≤ 25 kg/m2 25.01–29.99 kg/m2 ≥ 30 kg/m2
Table 2. The results of the effects of age, gender and body mass index on the variable rate of the positive methacholine 
challenge test using a single and multiple logistic regression model
Adjusted coefficientsCrude coefficientsVariables
P-valueCIORP-value95% CIOR
0.300.97–1.010.990.570.974–1.0150.99Age
0.470.73–1.991.210.260.811–2.1721.33Gender
0.031.005–1.1211.060.041.003–1.114 1.06BMI
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between 18 and 70 years old, was conducted in Austra-
lia. In this study, a high dose of methacholine was used 
to determine the sensitivity and maximum response to 
methacholine. Resistance and reaction of the respira-
tory system by using the forced oscillation technique, 
dyspnea by using the Borg score and lung volumes by 
using plethysmograph were measured. The results of this 
qualitative study showed that the rate of change in the 
airway resistance was similar in both groups, but obese 
people had more negative reactions to treatment and 
severity of their dyspnea was higher. According to the re-
sults, obesity reduces lung volume but the sensitivity and 
maximum lung response to methacholine do not change. 
Obesity increases the dyspnea symptoms [8]. 
An investigation in India (2014) was performed on 
424 adults who did not develop asthma. The results of 
this quantitative test revealed a significant relationship 
between spirometry parameters and BMI in healthy 
obese people, especially in women [9].
A study in Italy (2002) was done on 1426 people aged 
over 24 years in relation to BMI changes. Spirometry was 
performed on participants and then lung volume was 
measured with respect to BMI and gender. The results of 
this quantitative study showed that BMI of men rather 
than of women has a significant association with lung 
capacity. Also, BMI is a better prediction for lung volume 
in men [10]. 
In 2012, a quantitative study was conducted on 4217 
adults whose results demonstrated that obesity only in 
women can increase airway sensitivity and bring its mod-
erate degree. This effect can be due to changes in obesity 
on the lung function [11]. 
A survey (2008) was performed on 861 adults with 
regard to obesity and AHR. Among them, 401 participants 
had AHR and the medium dose of methacholine was 4.16 
±2.25 mg/ml. The results showed that obesity increases 
the risk of hypersensitivity airways and leads to the de-
velopment of asthma [12].
A survey in Chile (2005) was conducted on 1232 indi-
viduals with respect to obesity and asthma. People in this 
study suffered from atopy (skin test) and had high sen-
sitivity of bronchi. The results of this quantitative study 
showed that BMI was negatively associated with airway 
hypersensitivity and waist size has no relationship to 
asthma symptoms and has a negative association with 
hypersensitivity of the airways [13]. 
In a study in India (2014) which was conducted on 158 
people (90 men and 68 women) based on the impact of 
gender and BMI in lung volume change and PFTs were per-
formed on all patients. It revealed that gender diversity 
was found significant at the normal levels of pulmonary 
function tests. Body mass index in men was negatively 
associated with forced vital capacity and the grades of BMI 
in women show better prediction of lung function [11].
In 2012, a study in South Korea was carried out on 
852 patients with asthma to investigate the relationship 
between obesity and AHR. Patients were divided into 
4 groups: obese, overweight, normal and underweight 
and also the samples were tested by the methacholine 
challenge test to determine AHA. The results of this 
quantitative study presented that obesity is generally 
a driving factor for asthma but obesity in people with 
asthma is negatively correlated with the severity of AHR 
and asthma symptoms. Obesity in patients with asthma 
is significantly associated with the prevalence of dyspnea 
but negatively correlated with AHR [14]. 
A research in America (2002) was performed with re-
gard to BMI and the development of AHR. Sixty-one men 
who did not have AHR in the initial methacholine chal-
lenge test but developed AHR 4 years later. Two hundred 
forty-four control samples participated in this study. The 
effects of initial BMI and its changes in the development 
of AHR were evaluated. The results of this qualitative 
study showed that in the men’s group, both low and high 
BMI were associated with an increase in AHR [15]. 
A survey in 2012 was conducted on 200 patients 
(100 obese men and 100 non-obese men). The results 
of this qualitative study illustrated that in obese people, 
there are different reductions in respiratory function that 
is due to a decrease in chest expansion power and limi-
Table 3. Distribution of the methacholine dose used in people with a positive methacholine test based on body mass 
index subgroups
Parameter Dose met-C Total
≤ 1 1–4 ≤ 4
BMI [kg/m2] ≤ 25 Count 20 4 62 86
% within BMI_C 23.3 4.7 72.1 100.0
25.01–29.99 Count 37 8 51 96
% within BMI_C 38.5 8.3 53.1 100.0
≥ 30 Count 28 5 41 74
% within BMI_C 37.8 6.8 55.4 100.0
Total Count 85 17 154 256
% within BMI_C 33.2 6.6 60.2 100.0
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tation in increasing the volume of the chest cavity and 
consequently reduction in respiratory volume and total 
lung volume reduction [16].
Conclusions
The results of this study show that the prevalence of 
AHR is higher in fat people. With increasing severity of 
obesity, the hypersensitivity of airways rises. 
This investigation illustrates that BMI increases along 
with AHR. This result of this study is different from some 
other studies that examined the association between 
BMI and AHR. In the survey conducted by Salome et al., 
it was shown that obesity causes a decrease in lung vol-
umes, but it does not affect the response threshold of 
airways to methacholine.
Also the survey of Bustos et al. was shown that obe-
sity and AHR has negative relationship and litonjua study 
demonstrated that airway hypersensitivity is more cur-
rent in fat and thin men.
The result of our study is similar to the survey of 
Kwon et al. They showed that obesity is generally a risk 
factor for, the hypersensitivity of airways, which was low-
er in obese persons with asthma. This study displayed 
that the relationship between obesity and hypersensi-
tivity of airways is not affected by sex. In other words, 
the prevalence of AHR is not different among obese men 
and women. Our results are against the conclusion of 
Kwon et al. We demonstrated that the association be-
tween obesity and hypersensitivity of airways is found 
among women.
The result of our investigation is inconsistent with the 
study of Kwon et al. about the relationship between the 
severity of obesity and hypersensitivity of airways due 
to methacholine. Our study showed that the severity of 
obesity has a relationship with AHR, while in the study of 
Kwon et al., the obesity in asthma patients had a nega-
tive relationship with hypersensitivity of airways. Also it 
showed that obesity has been associated with intermedi-
ate sensitivity of airways among women.
In this domain, the largest study was conducted by 
Bruno et al. that demonstrated that the relationship of 
sex with BMI and with hypersensitivity of airways is 
related to multiple agents like leptin hormone and me-
chanical factors such as fat distribution in body of men 
and women and difference in airway diameter is a claim 
that has not been confirmed by other studies. On the 
other hand, however the number of patients has been 
high, there have not been any strong results to reject this 
relationship.
Also in our study, only intermediate sensitivity of 
airways in women has an association with obesity, so 
it is necessary to review other factors that influence the 
cause and aggravate sensitivity of airways and its rela-
tionship with asthma. It is anticipated that above risk 
factors or stimuli cause hypersensitivity of airways with-
out increasing the intensity or amount of stimuli or fac-
tors for hypersensitivity of airway.
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